Financial results - SANFER PHARM SRL

Financial Summary - Sanfer Pharm Srl
Unique identification code: 35801346
Registration number: J26/391/2016
Nace: 4729
Sales - Ron
45.605
Net Profit - Ron
-5.323
Employees
Open Account
Company Sanfer Pharm Srl with Fiscal Code 35801346 recorded a turnover of 2024 of 45.605, with a net profit of -5.323 and having an average number of employees of - . The company operates in the field of Comert cu amanuntul al altor produse alimentare, in magazine specializate having the NACE code 4729.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Sanfer Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - 4.857 19.078 12.182 21.892 27.688 45.469 50.392 48.806 45.605
Total Income - EUR - 4.857 19.078 12.182 21.892 27.688 45.469 50.417 53.317 45.605
Total Expenses - EUR - 4.394 14.448 9.805 16.897 20.546 39.686 45.992 49.303 50.929
Gross Profit/Loss - EUR - 463 4.629 2.377 4.996 7.142 5.783 4.424 4.014 -5.323
Net Profit/Loss - EUR - 318 4.057 2.012 4.339 6.311 4.582 3.138 3.359 -5.323
Employees - 0 0 0 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -6.0%, from 48.806 euro in the year 2023, to 45.605 euro in 2024. The Net Profit decreased by -3.340 euro, from 3.359 euro in 2023, to 0 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Sanfer Pharm Srl

Rating financiar

Financial Rating -
SANFER PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Sanfer Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Sanfer Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Sanfer Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Sanfer Pharm Srl - CUI 35801346

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - 540 402 269 273 195 119 69 30 57
Current Assets - 3.857 6.953 11.527 16.587 23.504 25.276 27.473 22.832 19.089
Inventories - 2.309 2.989 1.395 2.864 5.034 5.957 12.747 9.680 5.744
Receivables - 0 431 438 429 0 259 61 0 96
Cash - 1.548 3.534 9.694 13.294 18.470 19.061 14.664 13.152 13.250
Shareholders Funds - 362 4.413 6.344 10.559 16.671 18.756 21.952 19.399 13.312
Social Capital - 45 44 43 42 41 40 41 40 40
Debts - 4.034 2.943 5.452 6.300 7.028 6.639 5.589 3.462 5.835
Income in Advance - 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4729 - 4729"
CAEN Financial Year 4729
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 19.089 euro in 2024 which includes Inventories of 5.744 euro, Receivables of 96 euro and cash availability of 13.250 euro.
The company's Equity was valued at 13.312 euro, while total Liabilities amounted to 5.835 euro. Equity decreased by -5.979 euro, from 19.399 euro in 2023, to 13.312 in 2024.

Risk Reports Prices

Reviews - Sanfer Pharm Srl

Comments - Sanfer Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.